Advanced glycation end-products or glycation proteins can induce the release of pathophysiological substances such as IL-6, IL-8, MCP-1, ICAM-1, and IP-10 in conditions such as diabetic retinopathy [31]. Here, CCL2 is linked to diabetic retinopathy.